US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 10.550
  • +0.080+0.76%
Close Apr 18 16:00 ET
  • 10.550
  • 0.0000.00%
Post 16:02 ET
1.68BMarket Cap-7104P/E (TTM)

Neumora Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
85.54%252.1M
271.13%114M
85.82%56.86M
-42.75%135.87M
15.71%30.72M
-82.82%30.6M
82.06%31.31M
179.94%43.24M
148.46%237.32M
35.94%26.55M
Selling and administrative expenses
46.12%45.48M
56.16%11.24M
89.53%15.26M
26.78%31.12M
-5.80%7.2M
20.90%8.05M
23.47%7.79M
105.15%8.09M
192.50%24.55M
77.83%7.64M
-General and administrative expense
46.12%45.48M
56.16%11.24M
89.53%15.26M
26.78%31.12M
-5.80%7.2M
20.90%8.05M
23.47%7.79M
105.15%8.09M
192.50%24.55M
77.83%7.64M
Research and development costs
97.26%206.62M
336.88%102.77M
84.49%41.6M
-50.77%104.75M
24.40%23.52M
-86.85%22.55M
115.97%23.53M
205.56%35.15M
144.22%212.78M
24.13%18.91M
Operating profit
-85.54%-252.1M
-271.13%-114M
-85.82%-56.86M
42.75%-135.87M
-15.71%-30.72M
82.82%-30.6M
-82.06%-31.31M
-179.94%-43.24M
-148.46%-237.32M
-35.94%-26.55M
Net non-operating interest income expense
264.20%16.61M
147.09%5.65M
172.97%3.84M
4.56M
2.29M
1.41M
784K
86K
0
Non-operating interest income
264.20%16.61M
147.09%5.65M
172.97%3.84M
--4.56M
--2.29M
--1.41M
--784K
--86K
--0
----
Other net income (expense)
-141.98%-170K
-136.24%-104K
99.32%-1K
3,581.82%405K
168.01%287K
-243.69%-148K
-16.40%158K
-23.40%108K
100.29%11K
10.21%-422K
Other non- operating income (expenses)
-141.98%-170K
-136.24%-104K
99.32%-1K
3,581.82%405K
168.01%287K
-243.69%-148K
-16.40%158K
-23.40%108K
100.29%11K
10.21%-422K
Income before tax
-80.02%-235.66M
-285.35%-108.46M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Income tax
268K
0
Net income
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Net income continuous Operations
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Minority interest income
Net income attributable to the parent company
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
-78.54%-30.37M
-181.25%-43.04M
-139.05%-237.31M
-34.86%-26.97M
Basic earnings per share
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-207.98%-4.81
-4.36%-0.1852
83.52%-0.1931
-78.54%-0.1999
-181.25%-0.2833
-139.05%-1.5618
-34.86%-0.1775
Diluted earnings per share
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-207.98%-4.81
-4.36%-0.1852
83.52%-0.1931
-78.54%-0.1999
-181.25%-0.2833
-139.05%-1.5618
-34.86%-0.1775
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 85.54%252.1M271.13%114M85.82%56.86M-42.75%135.87M15.71%30.72M-82.82%30.6M82.06%31.31M179.94%43.24M148.46%237.32M35.94%26.55M
Selling and administrative expenses 46.12%45.48M56.16%11.24M89.53%15.26M26.78%31.12M-5.80%7.2M20.90%8.05M23.47%7.79M105.15%8.09M192.50%24.55M77.83%7.64M
-General and administrative expense 46.12%45.48M56.16%11.24M89.53%15.26M26.78%31.12M-5.80%7.2M20.90%8.05M23.47%7.79M105.15%8.09M192.50%24.55M77.83%7.64M
Research and development costs 97.26%206.62M336.88%102.77M84.49%41.6M-50.77%104.75M24.40%23.52M-86.85%22.55M115.97%23.53M205.56%35.15M144.22%212.78M24.13%18.91M
Operating profit -85.54%-252.1M-271.13%-114M-85.82%-56.86M42.75%-135.87M-15.71%-30.72M82.82%-30.6M-82.06%-31.31M-179.94%-43.24M-148.46%-237.32M-35.94%-26.55M
Net non-operating interest income expense 264.20%16.61M147.09%5.65M172.97%3.84M4.56M2.29M1.41M784K86K0
Non-operating interest income 264.20%16.61M147.09%5.65M172.97%3.84M--4.56M--2.29M--1.41M--784K--86K--0----
Other net income (expense) -141.98%-170K-136.24%-104K99.32%-1K3,581.82%405K168.01%287K-243.69%-148K-16.40%158K-23.40%108K100.29%11K10.21%-422K
Other non- operating income (expenses) -141.98%-170K-136.24%-104K99.32%-1K3,581.82%405K168.01%287K-243.69%-148K-16.40%158K-23.40%108K100.29%11K10.21%-422K
Income before tax -80.02%-235.66M-285.35%-108.46M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Income tax 268K0
Net income -80.23%-235.93M-286.31%-108.73M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Net income continuous Operations -80.23%-235.93M-286.31%-108.73M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Minority interest income
Net income attributable to the parent company -80.23%-235.93M-286.31%-108.73M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -80.23%-235.93M-286.31%-108.73M-80.71%-53.03M44.84%-130.9M-4.36%-28.15M83.52%-29.34M-78.54%-30.37M-181.25%-43.04M-139.05%-237.31M-34.86%-26.97M
Basic earnings per share 24.53%-3.63-269.57%-0.6846-490.32%-1.14-207.98%-4.81-4.36%-0.185283.52%-0.1931-78.54%-0.1999-181.25%-0.2833-139.05%-1.5618-34.86%-0.1775
Diluted earnings per share 24.53%-3.63-269.57%-0.6846-490.32%-1.14-207.98%-4.81-4.36%-0.185283.52%-0.1931-78.54%-0.1999-181.25%-0.2833-139.05%-1.5618-34.86%-0.1775
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion----Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg